EIF4E and cancer: Restraining eIF4E availability by the action of 4E-BP led to a preferential inhibition of translation of weak transcripts with an impact on cancer progression (De Benedetti and Graff, 2004; Hsieh et al., 2012; Musa et al., 2016).